PolyPeptide Group | WebDisclosure

Basculer en Français

10830	Companies
234984	Keywords
163871	Articles
125792	Press releases

Home
Companies
PolyPeptide Group

BRIEF

published on 08/13/2026 at 07:05, 2 hours 28 minutes ago

PolyPeptide annonce une forte croissance au premier semestre 2026 et met à jour ses perspectives pour l'exercice complet.

Perspectives À Moyen Terme Croissance Des Revenus Amélioration De L'EBITDA Extension De Capacité Thérapeutiques Métaboliques
BRIEF

published on 08/13/2026 at 07:05, 2 hours 28 minutes ago

PolyPeptide Reports Robust H1 2026 Growth and Updates Full-Year Outlook

Revenue Growth Capacity Expansion EBITDA Improvement Mid-term Outlook Metabolic Therapeutics
PRESS RELEASE

published on 08/13/2026 at 07:00, 2 hours 33 minutes ago

PolyPeptide delivers +42% growth in H1 2026 and improved EBITDA margin; 2026 full-year guidance updated, now expecting 25-30% revenue growth and high-teens EBITDA margin
PolyPeptide Group announces strong H1 2026 results: +42% revenue growth and improved EBITDA margin. 2026 full-year guidance raised to 25-30% growth and high-teens EBITDA margin

Revenue Growth EBITDA Margin PolyPeptide Group Full-year Guidance H1 2026
BRIEF

published on 07/20/2026 at 00:50, 24 days 8 hours ago

Samsung Biologics' Tender Offer for PolyPeptide Group

Financial Results Tender Offer Acquisition Strategy PolyPeptide Growth Samsung Biologics
BRIEF

published on 07/20/2026 at 00:50, 24 days 8 hours ago

Offre publique d'achat de Samsung Biologics sur PolyPeptide Group

Résultats Financiers Offre Publique D'achat Stratégie D'acquisition Samsung Biologics Croissance Des Polypeptides
PRESS RELEASE

published on 07/20/2026 at 00:45, 24 days 8 hours ago

PolyPeptide Group: Samsung Biologics announces tender offer to acquire PolyPeptide Group AG for CHF 44.31 per share
Samsung Biologics announces tender offer to acquire PolyPeptide Group AG at CHF 44.31 per share, reflecting growth and profitability. PolyPeptide reports marked acceleration in H1 2026 results

Profitability Growth Tender Offer PolyPeptide Group AG Samsung Biologics
BRIEF

published on 04/14/2026 at 07:05, 3 months 29 days ago

PolyPeptide Group Observes Market Speculation Regarding Potential Takeover

Revenue Growth Strategic Review PolyPeptide Group Market Speculation Takeover Interest
BRIEF

published on 04/14/2026 at 07:05, 3 months 29 days ago

PolyPeptide Group observe les spéculations du marché concernant une potentielle prise de contrôle

Croissance Des Revenus Revue Stratégique Groupe Polypeptide Spéculation Du Marché Intérêt Pour La Prise De Contrôle
PRESS RELEASE

published on 04/14/2026 at 07:00, 3 months 29 days ago

PolyPeptide Group AG takes note of market rumors and speculation
PolyPeptide Group AG acknowledges market rumors and speculation regarding potential takeover interest, conducting a review of strategic options in coordination with majority shareholder Draupnir Holding B.V

Strategic Options PolyPeptide Group Shareholder Review Market Rumors Takeover Interest
BRIEF

published on 04/08/2026 at 18:15, 4 months 4 days ago

L'assemblée générale annuelle 2026 de PolyPeptide Group obtient un large consensus.

Conseil D'administration Groupe Polypeptide Approbation De La Rémunération Assemblée Générale Annuelle 2026 États Financiers 2025

1 2 ... 8

Accesswire

Published on 08/13/2026 at 09:05, 28 minutes ago

Battery X Metals Appoints Lithium-Ion Battery and Electric Vehicle Entrepreneur William Fan as President to Advance Development of Its Patent-Pending Lithium-Ion Battery Rebalancing Technology Platform and Corporate Growth Initiatives
Published on 08/13/2026 at 08:00, 1 hour 33 minutes ago

Battery X Metals Maintains Y Lithium Project Claims in Good Standing and Evaluates Phase I Exploration Program
Published on 08/13/2026 at 07:30, 2 hours 3 minutes ago

Battery X Metals Announces Closing of Second Tranche of Private Placement to Advance Corporate Growth Initiatives
Published on 08/13/2026 at 00:30, 9 hours 3 minutes ago

Aton Closes CAD$4 Million Private Placement
Published on 08/12/2026 at 23:30, 10 hours 3 minutes ago

CCL Industries Announces Record Results for 2026 Second Quarter

View all ACCESSWIRE

EQS Group

Published on 08/13/2026 at 09:17, 15 minutes ago

EQS-Adhoc: InTiCa Systems SE: InTiCa Systems SE resolves to prepare the change from the regulated market (Prime Standard) to the Scale segment of the Frankfurt Stock Exchange
Published on 08/13/2026 at 09:05, 28 minutes ago

EQS-Adhoc: Schweizer Electronic AG decides to move from the regulated market to the Scale segment
Published on 08/13/2026 at 09:00, 33 minutes ago

Original-Research: INDUS Holding AG (von NuWays AG): BUY
Published on 08/13/2026 at 09:00, 33 minutes ago

Original-Research: DO & CO AG (von NuWays AG): BUY
Published on 08/13/2026 at 09:00, 33 minutes ago

Original-Research: Scandinavian Astor Group AB (von NuWays AG): BUY

Les Echos

Published on 08/11/2026 at 17:45, 1 day 15 hours ago

DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 15 hours ago

Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 15 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 15 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 2 days 15 hours ago

Weekly share buyback

View all LES ECHOS COMFI WIRE